The HIDTA Enhancement Act of 2025 is to be introduced shortly by Senators Mark Kelly (D-AZ), Shelley Moore Capito (R-WV), Catherine...

The Addiction Policy Forum invites organizations and families to sign on to a national letter of support for the bipartisan Halt All...

The U.S. Drug Enforcement Administration (DEA) has introduced three new telemedicine rules to maintain the accessibility of telehealth...

Recent research suggests that semaglutide, a medication primarily used for type 2 diabetes and weight management, may also help reduce alcohol consumption. The study published in JAMA Psychiatry found that patients with alcohol use disorder (AUD) who were prescribed GLP-1 drugs, popularly known by their brand names Ozempic and Wegovy, had a significantly lower risk of hospitalization for alcohol-related issues. Background on Semaglutide and Liraglutide Semaglutide and liraglu

The U.S. House of Representatives passed the Halt Lethal Trafficking (HALT) Fentanyl Act, which permanently schedules fentanyl-related substances as Schedule 1 under the Controlled Substances Acts. Led by Congressman Morgan Griffith (R-VA) and Bob Latta (R-OH),  the measure passed the house with a 312-108 bipartisan vote. The bill champions released in a statement: “ The ongoing fentanyl crisis has been fueled in part by a rise in lethal fentanyl-related substances. We are pl

As a leading cause of death for people under the age of 65, suicide risk increases for those within a jail or carceral setting, even for just one night. Justice-involved individuals who experience mental health disorders, including substance use disorder (SUD), are five times more likely to consider suicide than the general public.  In this Ask the Expert series, Dr. Lauren Weinstock discusses the importance of identifying suicide risk, specifically in jails, and how doing so